Advancing discovery of risk-altering variants for complex diseases by functionally informed fine-mapping
- PMID: 35298913
- DOI: 10.1016/j.neuron.2022.02.018
Advancing discovery of risk-altering variants for complex diseases by functionally informed fine-mapping
Abstract
Pinpointing causal variants at risk loci identified by genome-wide association studies (GWAS) has been a great challenge. In this issue of Neuron, Zhang et al. present a fine-mapping approach, RefMap, integrating functional genomics with GWAS summary statistics to prioritize causal variants for amyotrophic lateral sclerosis.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis.Neuron. 2022 Mar 16;110(6):992-1008.e11. doi: 10.1016/j.neuron.2021.12.019. Epub 2022 Jan 18. Neuron. 2022. PMID: 35045337 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources